Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 11
2003 15
2004 12
2005 20
2006 19
2007 12
2008 20
2009 16
2010 18
2011 15
2012 20
2013 19
2014 32
2015 35
2016 38
2017 35
2018 27
2019 33
2020 41
2021 23
2022 32
2023 20
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

472 results

Results by year

Filters applied: . Clear all
Page 1
Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications.
Marzolini C, Kuritzkes DR, Marra F, Boyle A, Gibbons S, Flexner C, Pozniak A, Boffito M, Waters L, Burger D, Back DJ, Khoo S. Marzolini C, et al. Among authors: burger d. Clin Pharmacol Ther. 2022 Dec;112(6):1191-1200. doi: 10.1002/cpt.2646. Epub 2022 Jun 7. Clin Pharmacol Ther. 2022. PMID: 35567754 Free PMC article. Review.
Clinical Pharmacokinetics and Pharmacodynamics of Micafungin.
Wasmann RE, Muilwijk EW, Burger DM, Verweij PE, Knibbe CA, Brüggemann RJ. Wasmann RE, et al. Among authors: burger dm. Clin Pharmacokinet. 2018 Mar;57(3):267-286. doi: 10.1007/s40262-017-0578-5. Clin Pharmacokinet. 2018. PMID: 28791666 Free PMC article. Review.
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.
Turkova A, White E, Kekitiinwa AR, Mumbiro V, Kaudha E, Liberty A, Ahimbisibwe GM, Moloantoa T, Srirompotong U, Mosia NR, Puthanakit T, Kobbe R, Fortuny C, Kataike H, Bbuye D, Na-Rajsima S, Coelho A, Lugemwa A, Bwakura-Dangarembizi MF, Klein N, Mujuru HA, Kityo C, Cotton MF, Ferrand RA, Giaquinto C, Rojo P, Violari A, Gibb DM, Ford D; ODYSSEY trial team. Turkova A, et al. Lancet Child Adolesc Health. 2023 Oct;7(10):718-727. doi: 10.1016/S2352-4642(23)00164-5. Epub 2023 Aug 8. Lancet Child Adolesc Health. 2023. PMID: 37562418 Free article. Clinical Trial.
Cobicistat: A case of mislabelled drug-drug interaction risk?
Burger DM, Calmy A, Marzolini C. Burger DM, et al. Br J Clin Pharmacol. 2020 May;86(5):834-836. doi: 10.1111/bcp.14262. Epub 2020 Mar 6. Br J Clin Pharmacol. 2020. PMID: 32144787 Free PMC article. No abstract available.
Drug-drug interactions with raltegravir.
Burger DM. Burger DM. Eur J Med Res. 2009 Nov 24;14 Suppl 3(Suppl 3):17-21. doi: 10.1186/2047-783x-14-s3-17. Eur J Med Res. 2009. PMID: 19959412 Free PMC article. Review.
Cardiovascular Risk Management and Hepatitis C: Combining Drugs.
Smolders EJ, Ter Horst PJG, Wolters S, Burger DM. Smolders EJ, et al. Among authors: burger dm. Clin Pharmacokinet. 2019 May;58(5):565-592. doi: 10.1007/s40262-018-0710-1. Clin Pharmacokinet. 2019. PMID: 30259390 Free PMC article. Review.
The role of formulation on the pharmacokinetics of antiretroviral drugs.
Bastiaans DE, Cressey TR, Vromans H, Burger DM. Bastiaans DE, et al. Among authors: burger dm. Expert Opin Drug Metab Toxicol. 2014 Jul;10(7):1019-37. doi: 10.1517/17425255.2014.925879. Epub 2014 May 30. Expert Opin Drug Metab Toxicol. 2014. PMID: 24877605 Review.
472 results